<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00591695</url>
  </required_header>
  <id_info>
    <org_study_id>EAES-1</org_study_id>
    <nct_id>NCT00591695</nct_id>
  </id_info>
  <brief_title>Enteral Stents for Colonic Obstruction</brief_title>
  <acronym>ESCO</acronym>
  <official_title>Prospective, Randomised European Multicentric Study, Comparing Enteral Stent Followed by Elective Surgery Versus Emergency Surgical Treatment in Malignant Colonic Obstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>European Association for Endoscopic Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>European Association for Endoscopic Surgery</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to verify whether stent positioning for malignant obstruction of
      the colon and rectum followed by elective surgery allows reduction of postoperative
      complications and hospital stay without worsening of evolution of the neoplastic illness,
      compared to emergency surgery.

      Primary endpoint will be 60 days postoperative morbidity. Others endpoints will be
      postoperative mortality, length of hospital stay, need for analgesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction &amp; background In emergency surgery, although surgical and resuscitation
      techniques were improved, the postoperative complications and mortality rates are still high
      and however higher than for those patients that underwent to elective surgery (1-3). Using a
      Metallic prosthesis stent in an obstructed colon allows to transform an emergency surgical
      case into an elective surgery case. This allows to restore the bowel transit and to operate
      in elective condition reducing morbidity, mortality and the need of an enterostomy (4-10).

      Although there are recent outcomes on literature about use of a decompressive stent before
      surgery in obstructed patients from malignant colic tumours, there are no prospective and
      randomised studies were stent positioning followed by elective surgery is compared with
      emergency surgery.

      Study design Prospective, randomized multicentric clinical trial where samples are patients
      with emergency room diagnosis of obstructing colonic neoplasm.

      Once informed and obtained consent, patients will be included in the study and randomized in
      one of the two branches of the study: A.- enteral stent positioning followed by second time
      resection in the same hospital stay. B.- emergency surgical treatment consisting in Hartmann
      operation or resection with same time anastomosis. Results from transit reconstruction in
      patients underwent Hartmann operation will be considered in the study.

      Short term clinical evolution control in order to determine postoperative morbility and
      mortality, hospital stay.

      Follow-up will be performed to evaluate survival rate and disease free survival.

      Endpoints To evaluate and compare the results obtained using enteral stent followed by
      elective surgery versus common emergency surgical techniques.

      Primary endpoint will be 60 days postoperative morbidity. Others endpoints will be:
      postoperative mortality, length of hospital stay, need for analgesia. Long term follow up
      with specific instrumental controls (CT scan, US, colonoscopy or RX clysma) to identify
      disease recurrences or metastases as cost analysis and patient's quality of life will also be
      evaluated.

      Statistics &amp; randomization In prospective series analysed in different centres, the incidence
      of postoperative complications in patients underwent to emergency colonic surgery was 35%.
      The positioning of the stent associated to second time surgical elective treatment is
      characterized by 15% of morbidity (stent: 5%, surgery: 10%). The number of patients needed to
      carry on the study making statistically significant this difference (35% vs 15%) with an
      error alpha = 0.05 and beta = 0.2 and estimating a loss of 5% of the samples, is 72 patients
      in each group.

      Randomization will be stratified for local extension of tumour (T4 vs others) and for
      presence or not of liver metastases.

      Main selection criteria Inclusion of patients with malignant colonic obstruction localized
      between promontorium and splenic flexure and diagnosed by CTScan. Those patients with
      peritonitis, pneumoperitoneum, synchronic colonic tumour, pregnant or haemodynamic
      instability will be excluded.

      Follow-up Same follow-up as patients diagnosed and treated for Colon Cancer following the
      protocol of each center, never less than 3 years. During follow-up required complementary
      studies will be performed in each case in order to evaluate local recurrence or distant
      metastases. Also quality of life and costs will be evaluated.

      Expected results: reduction of postoperative complications and hospital stay in patients
      submitted to stent positioning without worsening of evolution of the neoplastic illness.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of postoperative complications</measure>
    <time_frame>60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative mortality</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>success percentage of stent positioning in emergency</measure>
    <time_frame>at stent positioning</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>percentage of complications related to stent positioning</measure>
    <time_frame>at stent positioning</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life and survival</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost differences</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oncological results (local and distant recurrence rate)</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">144</enrollment>
  <condition>Malignant Colorectal Obstruction</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>positioning in emergency of a prosthetic metallic self-expanding stent followed, in case of successful colic decompression, by an elective surgical (laparoscopic or open) resection of the tumour</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>emergency surgery performed in these ways: Resection followed by enterostomy (Hartmann procedure), 'On table' washing and primary anastomoses, Subtotal colectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stent bridge to surgery + elective surgery</intervention_name>
    <description>positioning in emergency of a metallic self-expanding stent followed, in case of successful colic decompression, by an elective surgical (laparoscopic or open) resection of the tumour</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Colorectal stenting with metallic self-expanding stent + elective surgery</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Emergency Surgery</intervention_name>
    <description>Emergency surgery performed in these ways: Resection followed by enterostomy (Hartmann procedure), 'On table' washing and primary anastomoses, Subtotal colectomy</description>
    <arm_group_label>B</arm_group_label>
    <other_name>Resection followed by enterostomy (Hartmann procedure)</other_name>
    <other_name>'On table' washing and primary anastomoses</other_name>
    <other_name>Subtotal colectomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  malignant colonic obstruction localized between splenic flexure and 15 cm from anal
             margin diagnosed by CTScan.

          -  Possibility of endoscopy and stent location during next 24 h after diagnostic.

          -  Clinical occlusion to gas and faeces.

          -  Informed consent obtained from the patient or from a relative in case of inability.

        Exclusion Criteria:

          -  Bowel perforation diagnosed by clinical exploration and complementary studies.

          -  Associated pathologies contraindicating general anaesthesia and/or haemodynamic
             instability.

          -  Impossibility to gain a valid informed consent or refusal from the patient.

          -  Patients with multiple liver metastases diagnosed by CTScan at the moment of
             diagnostic and not considered operable with curative intention following the standards
             of every center.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mario Morino, Professor of Surgery</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of TORINO - European Association for Endoscopic Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eduardo M Targarona, Professor of Surgery</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundaci√≥ Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Surgery, Minimally Invasive Surgery Center, University of Torino</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.escostudy.zapto.org</url>
    <description>website for randomization and data collection of patients and information of study</description>
  </link>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2007</study_first_submitted>
  <study_first_submitted_qc>December 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2008</study_first_posted>
  <last_update_submitted>January 20, 2016</last_update_submitted>
  <last_update_submitted_qc>January 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>European Association for Endoscopic Surgery</investigator_affiliation>
    <investigator_full_name>Alberto Arezzo</investigator_full_name>
    <investigator_title>Assistant Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>Malignant Colorectal Obstruction</keyword>
  <keyword>Stent Bridge to Surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

